To date over 100 different nucleotide modifications have been identified in RNA (see:
http://modomics.genesilico.pl/ and http://mods.rna.albany.edu). Most of these modifications are present in structural RNAs (e.g. tRNAs and rRNAs), but a few are also present in messenger RNAs (mRNAs) likely affecting all aspects of gene expression [1] . The most prominent modifications in mRNAs are inosine (I), pseudouridine (Ψ), N6-methyladenosine (m6A), N1-methyladenosine (m1A), 5-methylcytosine (m5C) and 5-hydroxymethylcytosine (hm5C, Figure   1 ). Here we recapitulate our current knowledge about the genes directing these modifications in humans and model organisms (Table 1) and what their roles are in development and disease (Table 2) .
Inosine
The most common modification in mRNA is inosine (I) resulting from hydrolytic deamination of adenine (A) catalyzed by ADARs (Adenosine Deaminases Acting on RNA), which occurs in double stranded RNA ( Figure 1 ). This process is called A-to-I editing and changes the coding because inosine behaves as guanosine and thus base-pairs with cytidine [2] . In protein-coding sequences, A-to-I editing is promoted by the formation of an imperfect fold-back RNA structure between the exonic region containing the editing site and the so-called editing-site complementary sequence (ECS), which is mainly found in intronic regions [3] . Therefore, it has been suggested that RNA editing predominantly occurs before splicing. In addition, ADAR2 edits its own transcript to introduce a new 3' splice site, which in turn results in ADAR2 truncation [1] .
Vertebrates have three adar genes but one, adar3, appears to encode a catalytically inactive protein [2] . Historically, A-to-I editing had been found in transcripts of a few ion channel genes and has since expanded to about 80 protein-coding genes [2] . Although lethality of adar2 mutant mice suffering from epileptic seizures can be rescued by introducing the Q/R edited cDNA of the glutamate receptor GluR2 (GRIA2), recoding for example in AZIN1, COG3 and GRIA2 is functionally important [2, 7] . Since loss of adar1 in mice leads to aberrant activation of interferon signaling triggered by double-stranded RNA, it is thought that an important function of editing lies also in the immune system. Recent deep-sequencing revealed the largest number of inosines (approximately 15,000 in human genome) in non-coding repetitive regions, mainly in Alu elements, in 5′ and 3′ untranslated regions (UTRs) and long interspersed elements (LINE) [8] . Herein, the presence of inversely repetitive regions allows the formation of fold-back structures, which can be recognized by the dsRBDs of ADAR enzymes.
One of the most interesting aspects of RNA editing is that I:U mismatch base pairs are less stable than A:U pair [9], therefore the deamination of adenosine in these duplexes destabilizes their overall structure. This feature of RNA editing appears to play an essential role in preventing an aberrant immune response in the presence of endogenous dsRNA that may otherwise trigger the interferon response. Accordingly, these I:U mismatches escape recognition by RIG-I (retinoic acid-inducible gene I)-like cytoplasmic viral sensor proteins and thus protect cells from an aberrant interferon response [10] .
Mutations that compromise A to I editing are linked to several disease phenotypes. The AicardiGoutières syndrome (AGS), most frequently characterized by autosomal-recessive inherited mutations in adar1 gene, manifests as a childhood inflammatory disorder with aberrant interferon expression [11] . Another genetic disorder associated with adar1 is the rare autosomaldominant pigmentary genodermatosis dyschromatosis symmetrica hereditaria (DSH) disorder characterized by a mixture of hyper-and hypo-pigmented macules on hands and feet [12] .
Hypo-editing of glutamate receptor GluR2 pre-mRNA by downregulated ADAR2 activity has also been associated with amyotrophic lateral sclerosis (ALS) and human glioma [13, 14] . Editing in the serotonin receptor 5-HT 2c R pre-mRNA has been linked to various psychiatric disorders including anxiety, bipolar disorder, autism, depression and schizophrenia [2] .
In addition, dysregulation of both ADAR1 and/or ADAR2 editing in protein coding genes or miRNAs has also been linked to various cancers including hepatocellular carcinoma, chronic myeloid leukemia squamous cell carcinoma and glioblastoma [15] [16] [17] [18] [19] . Further to this, a global analysis of A to I editing revealed altered profiles in many cancers and indicates that editing selectively affects susceptibility to drug treatment [7] .
Pseudouridine
Pseudouridine (Ψ) represents the most abundant chemical modification detected in structural RNAs, but is also present in mRNAs. Ψ derives from enzymatic isomerization of uridine by rotation of the nitrogen at the C6 position ( Figure 1 ) [20] . Pseudouridylation can be catalyzed through two different mechanisms: RNA-dependent and RNA-independent [21] . The former process is carried out by RNA-protein complexes, consisting of a box H/ACA snoRNA, which guides four proteins including the putative rRNA pseudouridine synthase Cbf5 in yeast or DKC1 in humans to introduce the modification site-specifically [21] .
The RNA-independent mechanism for pseudouridylation relies on the evolutionary conserved PUS (pseudouridine synthase) domain enzymes (Table 1 ) [22] . In yeast seven PUS domain containing enzymes are present (PUS1-4, 6,7 and 9), Drosophila has 11, while the human genome contains 23 genes with a PUS domain. Recent pseudouridine profiling analyses in yeast and human cells revealed the presence of this modification predominantly in 5'UTRs and in the coding sequence of a few transcripts [23] [24] [25] . Further genetic analyses in yeast allowed for assigning individual pseudouridines to each of the seven pseudouridine synthases (PUS1-4, 6,7 and 9), but all of these enzymes modify both mRNAs and structural RNAs [23] . In HEK293 cells most of the Ψ modifications are introduced by PUS1, PUS4 and PUS7 [25] .
Interestingly, pseudouridine levels in several mRNAs are increased after heat shock and this involved cytoplasmic translocation of PUS7, highlighting a dynamic program under stress conditions, whereas Cbf5-mediated pseudouridylation is stress-independent. The function of Ψ in mRNA is not known, but might involve alteration of RNA structure, or might alternatively target modified mRNAs to heat shock-induced stress granules [25] . Recently, it has also been shown that Ψ can suppress translational termination if present in either of the three stop codons
Defects in DKC1 (H/ACA ribonucleoprotein complex subunit 4) and PUS1 (tRNA pseudouridine synthase A) have been both associated to human disorders (Table 2) 
N6-methyladenosine
The most abundant internal modification in mRNA is N6-methyladenosine (m6A, Figure 1 ) [33, 34] . Although first discovered in the 70s, lack of molecular and genetic tools has hindered identifying its functional relevance until recent anti-m6A antibody pull-down and highthroughput sequencing approaches [35] [36] [37] [38] . These efforts revealed transcriptome-wide maps of m6A in humans, plants and yeast, but also indicated a high percentage of false positives due to the limited specificity of anti-m6A antibodies [37] [38] [39] [40] . In humans, about 12,000 m6A sites were mapped on 7000 coding and 300 non-coding genes with an average of 3-5 sites per transcript [37] . Interestingly, m6A preferentially peaks in the 5'UTR and around the stop codon, but is also present in long exons in the consensus sequence RRACH (where R is a purine, and H is adenosine, cytidine or uracil) [37, 38, 41, 42] . In accordance with their localization in UTRs, presence of m6A has been shown to affect mRNA stability and translation [43] [44] [45] . Although m6A is also found in introns, its exact roles in splicing regulation remain to be established.
The proteins governing the dynamic m6A landscape can be divided into three classes: writers, readers, and erasers. Biochemical characterization of the human methylosome, the m6A writer, revealed two complexes of 200 kDa and 875 kDa containing the catalytic activity MT-A encoded by the mettl3 gene, which places the m6A epimark in single stranded RNA [46] . Recent proteomics and reconstitution assays identified further components including a second catalytic subunit METTL14, the splicing factors WTAP (Wilm's tumor associating protein) and Virilizer as well as a number of other proteins [47] [48] [49] [50] . Orthologues of mettl3 and mettl14 are found in Drosophila, plants and budding yeast, but seem to be absent in worms and fission yeast [50, 51] .
Loss of mettl3 results in embryonic lethality in mice and plants, while in S. cerevisiae, expression of the mettl3 orthologue inducer of meiosis4 (ime4) and consequently m6A are found only during meiosis [50, 52, 53] . Other functions include roles in mammalian embryonic stem cell renewal, the circadian clock and cap independent translation for directing the heat-shock response [52, [54] [55] [56] [57] .
Readers of the m6A epimark belong to the YT521-B homology (YTH) protein family. The YTH domain has a fifty fold higher affinity towards m6A compared to unmodified adenosine. Humans have five YTH proteins (YTHDF1-3 and YTHDC1 and 2), Drosophila has two (CG6422 and YT521-B) and S. cerevisiae has one (Mrb1), while plants have thirteen orthologues [33] . Intriguingly, the fission yeast YTH orthologue Mmi1 binds RNA in a different mode than the other YTH proteins consistent with the absence of m6A in mRNA in this organism [58] .
While reader proteins directly bind the modified nucleotide, m6A has also been shown to promote RNA structural remodeling to favor recruitment of the RNA binding protein HNRNPC in a stem loop of the MALAT1 non-coding RNA [59] .
Eraser proteins are m6A demethylases making this modification completely reversible. Currently two such proteins are known: Fat mass and obesity associated (FTO) and ALKBH5, a member of the Fe2/α-ketoglutarate-dependent dioxygenase family [60, 61] .
Whereas alkbh5 knockout mice have impaired male fertility [62] , alterations in FTO expression have been connected to altered energy metabolism leading to obesity, type 2 diabetes, growth retardation, developmental delay, facial dysmorphism and cancer [63] [64] [65] [66] .
N1-methyladenosine
Yet another modification analysed for its genome-wide occurrence is N1-methyladenosine (m1A) [67, 68] . Elegantly, m1A can be converted to m6A by the Dimroth reaction and then analysed using the m6A antibody. This analysis revealed a dynamic m1A landscape with a predominant peak near the start codon in human and yeast mRNA in response to cellular stress. Noteworthy, the m1A modification harbours a positive charge under physiological conditions. This may affect the canonical base pairing, altering secondary and tertiary structure, or affect RNA-protein interactions. In contrast to the m6A modification, m1A leads to abortive reverse transcription, which can be employed to validate this modification [69] .
While the catalytic entity responsible for installing m1A is still not known, overexpression of the alkbh3 gene results in decreased m1A levels. This makes ALKBH3 a likely candidate for demethylating m1A in mRNAs [67] .
5-methylcytosine and 5-hydroxymethylcytosine
The methyl group in 5-methylcytosine (m5C) prevents the conversion to uracil by bisulfite treatment. Applying this feature in combination with high-throughput sequencing detected a considerable number of m5C in mRNA [70] . In mRNA, m5C is mainly present in untranslated regions in the proximity of Argonaute family protein binding sites suggesting roles in mRNA stability and translation [70] .
The only enzyme currently known to methylate cytosine in mRNA is NSUN2 (NOP2/Sun RNA methyltransferase family member 2) [70, 71] . Evolutionary conserved NSUN2 localizes to the nucleus, but in addition to mRNA also methylates cytosines in tRNAs as revealed by a mutant NSUN2 protein tethering itself to the site of methylation (Table 1 ) [72] .
NSUN2 is required for stem cell differentiation and cell proliferation, but has also been linked to human cancers [71, [73] [74] [75] [76] . In addition, methylation of the mRNA for intracellular cell adhesion molecule (ICAM-1) promotes inflammation via increased translation [77] . In accordance with NSUN2's increased expression in the brain, mutations have been identified that cause intellectual disability [78] .
Although Drosophila seems not have m5C DNA methylation, its genome contains a Ten-eleventranslocation (Tet) orthologue involved in DNA demethylation in vertebrates via hydroxylation of the methylgroup, which is then further modified to 5-formylcytosine and 5-carboxylcytosine leading to glycosylation and removal via DNA excision repair. This paradox is explained by the capacity of human TET3, but not TET1 or TET2, to hydroxylate m5C in RNA [79] . Accordingly, hm5C can be detected in RNA of animals and plants, but at lower levels than m5C [80] . Using an antibody against hm5C and high throughput sequencing 3058 hm5C methylation sites have been detected in 1597 transcripts in Drosophila S2 cells [81] . Although these levels are low, hm5C in mRNA is functionally relevant as Drosophila tet mutants die during pupal development and show defects in neuroblast proliferation [81] .
Noteworthy, tet-null ES cells genetically deprived of all TET enzymes, still show detectable levels of hm5C, suggesting that m5C oxidation can also be catalyzed by different enzymes or induced by cellular reactive oxygen species. Accordingly, the hm5C modification is also detectable in C. elegans and A. thaliana, which do not have orthologues of TET in their genomes [79] . 
Conclusions

